";s:4:"text";s:5350:" Amlodipine is a long acting calcium channel antagonist that selectively inhibits calcium ion influx across cell membranes. Prostacyclin Analogues: May enhance the hypotensive effect of Blood Pressure Lowering Agents.Quinagolide: May enhance the hypotensive effect of Blood Pressure Lowering Agents.QuiNIDine: Calcium Channel Blockers (Dihydropyridine) may decrease the serum concentration of QuiNIDine. Dosages of similarly metabolized drugs, particularly those of low therapeutic ratio, …
Blood pressure must be lowered at a rate appropriate for the patient's clinical condition.• Peripheral edema: The most common side effect is peripheral edema; occurs within 2 to 3 weeks of starting therapy.• Aortic stenosis: Use amlodipine with extreme caution in patients with severe aortic stenosis; may reduce coronary perfusion resulting in ischemia.• Heart failure: With the exception of amlodipine, calcium channel blockers should be avoided whenever possible in patients with heart failure with reduced ejection fraction (HFrEF). This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Elderly patients also show decreased clearance of amlodipine.Children <6 years: Limited data available: Oral: Initial: 0.1 mg/kg/dose once daily; titrate based on clinical response; maximum daily dose: 0.6 mg/kg/Children ≥6 years and Adolescents: Oral: Initial: 2.5 mg once daily; titrate based on clinical response; maximum daily dose: 10 mg/Children ≥6 years and Adolescents: Oral: Usual dosage range: 2.5 to 10 mg once daily; start dose low and increase as tolerated and based on symptom response (Gargh 2010; Kliegman 2020; Wigley 2015).A 1 mg/mL oral suspension may be made with tablets and either a 1:1 mixture of simple syrup and 1% methylcellulose or a 1:1 mixture of Ora-Plus and Ora-Sweet. 10 OVERDOSAGE 11 DESCRIPTION 12 CLINICAL PHARMACOLOGY . Management: Patients on lomitapide 5 mg/day may continue that dose. However, controversy exists regarding whether amlodipine adversely affects clopidogrel response and clinical outcome after percutaneous coronary intervention (PCI). Management: Consider an alternative for one of the interacting drugs. See manufacturer's labeling.• Polysorbate 80: Some dosage forms may contain polysorbate 80 (also known as Tweens). CYP3A inhibitors, by nature of inhibiting the enzyme that metabolizes amlodipine, Amlodipine is a long acting calcium channel antagonist that selectively inhibits calcium ion influx across cell membranes.Amlodipine ends up significantly reducing total vascular resistance without decreasing The mechanisms by which amlodipine relieves angina are: Conivaptan: May increase the serum concentration of CYP3A4 Substrates (High risk with Inhibitors).CycloSPORINE (Systemic): Calcium Channel Blockers (Dihydropyridine) may increase the serum concentration of CycloSPORINE (Systemic). Management: Concurrent use of felodipine or nisoldipine with itraconazole is specifically contraindicated. The lomitapide dose may then be titrated up to a max adult dose of 30 mg/day.Lormetazepam: May enhance the hypotensive effect of Blood Pressure Lowering Agents.Lovastatin: AmLODIPine may increase the serum concentration of Lovastatin. Nimodipine Canadian labeling contraindicates concomitant use with phenobarbital.Barbiturates: May enhance the hypotensive effect of Blood Pressure Lowering Agents.Benperidol: May enhance the hypotensive effect of Blood Pressure Lowering Agents.Brigatinib: May diminish the antihypertensive effect of Antihypertensive Agents.
8.3 Nursing Mothers . Excipient information presented when available (limited, particularly for generics); consult specific product labeling.Katerzia: 1 mg/mL (150 mL) [contains polysorbate 80, sodium benzoate]Inhibits calcium ion from entering the “slow channels” or select voltage-sensitive areas of vascular smooth muscle and myocardium during depolarization, producing a relaxation of coronary vascular smooth muscle and coronary vasodilation; increases myocardial oxygen delivery in patients with vasospastic angina.
Fluconazole and isavuconazonium likely exert weaker effects than other azoles and are addressed in separate monographs. Some combinations may be specifically contraindicated. Amlodipine is metabolized by cytochrome P450 (CYP) 3A4, so it was speculated that GLT may change the pharmacokinetic parameters of amlodipine through modulating the metabolism of CYP3A4 enzymes.